Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil vs sufentanil with propofol TCI for ambulatory hysteroscopic surgery
ChiCTR2200063939Phase 4Completed
- Sponsor
- Chongqing Health Center for Women and Children
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alfentanil, sufentanil and propofol in procedural pain (2 arms), sponsored by Chongqing Health Center for Women and Children. Primary endpoint: Overall incidence of adverse events. Started Oct 2022; status: completed.
02
Drugs
alfentanilsufentanilpropofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2200063939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063939.